ERBB2 and ductal breast carcinoma in situ: Heterogeneity in DCIS and its transition [5,39] partly manifests in the variation seen in clinicopathological features such as biological grade, ER/PR status, HER2 status [199,200], and luminal and basal subtypes [201,202].